IL-2 antibodies in type 1 diabetes and during IL-2 therapy

被引：0
|
作者：
Guillaume Churlaud
Michelle Rosenzwajg
Patrice Cacoub
David Saadoun
Dominique Valteau-Couanet
Nathalie Chaput
Alberto Pugliese
David Klatzmann
机构：
[1] AP-HP,Department of Internal Medicine and Clinical Immunology, National Reference Center for Autoimmune Systemic and Rare Diseases, Groupe Hospitalier Pitié
[2] Groupe Hospitalier Pitié-Salpêtrière,Salpêtrière
[3] Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B),Département de pédiatrie
[4] Sorbonne Université,Institut Gustave Roussy, Laboratoire d’Immunomonitoring en Oncologie
[5] INSERM,Diabetes Research Institute, Miller School of Medicine
[6] Immunology-Immunopathology-Immunotherapy (i3),Department of Medicine, Division of Endocrinology and Metabolism, Miller School of Medicine
[7] AP-HP,Department of Microbiology and Immunology, Miller School of Medicine
[8] Gustave Roussy,undefined
[9] CNRS-UMS 3655 and INSERM-US23,undefined
[10] Université Paris-Sud,undefined
[11] UFR de Pharmacie,undefined
[12] University of Miami,undefined
[13] University of Miami,undefined
[14] University of Miami,undefined
来源：
Diabetologia | 2018年 / 61卷
关键词：
Autoantibodies; Autoimmune disease; Autoimmunity; IL-2; Type 1 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2066 / 2068
页数：2
相关论文
共 50 条
  • [1] IL-2 antibodies in type 1 diabetes and during IL-2 therapy
    Churlaud, Guillaume
    Rosenzwajg, Michelle
    Cacoub, Patrice
    Saadoun, David
    Valteau-Couanet, Dominique
    Chaput, Nathalie
    Pugliese, Alberto
    Klatzmann, David
    DIABETOLOGIA, 2018, 61 (09) : 2066 - 2068
  • [2] IL-2 therapy in type 1 diabetes: "Trials" and tribulations
    Long, S. Alice
    Buckner, Jane H.
    Greenbaum, Carla J.
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 324 - 331
  • [3] Natural antibodies to IL-2
    Balsari, A
    Caruso, A
    BIOTHERAPY, 1997, 10 (01) : 25 - 28
  • [4] REGULATION OF IL-2 RECEPTORS EXPRESSION BY IL-2 AND IL-1
    NABHOLZ, M
    ERARD, F
    SEKALI, R
    LOWENTHAL, J
    CORTHESY, P
    COMBE, MC
    MACDONALD, HR
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 1304 - 1304
  • [5] Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes
    Baeyens, Audrey
    Perol, Louis
    Fourcade, Gwladys
    Cagnard, Nicolas
    Carpentier, Wassila
    Woytschak, Janine
    Boyman, Onur
    Hartemann, Agnes
    Piaggio, Eliane
    DIABETES, 2013, 62 (09) : 3120 - 3131
  • [6] Loss of immune tolerance to IL-2 in type 1 diabetes
    Louis Pérol
    John M. Lindner
    Pamela Caudana
    Nicolas Gonzalo Nunez
    Audrey Baeyens
    Andrea Valle
    Christine Sedlik
    Delphine Loirat
    Olivier Boyer
    Alain Créange
    José Laurent Cohen
    Ute Christine Rogner
    Jun Yamanouchi
    Martine Marchant
    Xavier Charles Leber
    Meike Scharenberg
    Marie-Claude Gagnerault
    Roberto Mallone
    Manuela Battaglia
    Pere Santamaria
    Agnès Hartemann
    Elisabetta Traggiai
    Eliane Piaggio
    Nature Communications, 7
  • [7] Loss of immune tolerance to IL-2 in type 1 diabetes
    Perol, Louis
    Lindner, John M.
    Caudana, Pamela
    Nunez, Nicolas Gonzalo
    Baeyens, Audrey
    Valle, Andrea
    Sedlik, Christine
    Loirat, Delphine
    Boyer, Olivier
    Creange, Alain
    Cohen, Jose Laurent
    Rogner, Ute Christine
    Yamanouchi, Jun
    Marchant, Martine
    Leber, Xavier Charles
    Scharenberg, Meike
    Gagnerault, Marie-Claude
    Mallone, Roberto
    Battaglia, Manuela
    Santamaria, Pere
    Hartemann, Agnes
    Traggiai, Elisabetta
    Piaggio, Eliane
    NATURE COMMUNICATIONS, 2016, 7
  • [8] Effective IL-2 therapy
    DenOtter, W
    Everse, LA
    Bernsen, MR
    Klein, WR
    Rutten, VPGM
    Stewart, R
    Hill, G
    Balemans, L
    Steerenberg, PA
    FiszerMaliszewska, L
    Dobrowolski, Z
    Zembala, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 24 - 24
  • [9] CYTOKINES IL-2 AND IL-6 IN CHILDREN WITH TYPE 1 DIABETES MELLITUS
    Sapunar, A.
    Markic, Josko
    Culic, S.
    Unic, I.
    Bosnjak, N.
    Kurtovic, A. Rodin
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S391 - S391
  • [10] Small Molecule Modification of the IL-2 Receptor: Implications for Therapy in Type 1 Diabetes
    Hulme, Maigan A.
    Wasserfall, Clive H.
    Brusko, Todd M.
    Haller, Michael J.
    Schatz, Desmond A.
    Ostrov, David A.
    Atkinson, Mark A.
    DIABETES, 2011, 60 : A401 - A401
12345